SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-14-001400
Filing Date
2014-11-25
Accepted
2014-11-25 16:20:11
Documents
2
Period of Report
2014-11-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DELMAR PHARMACEUTICALS, INC. 8-K f8k112514_delmar.htm 8-K 16016
2 DELMAR PHARMACEUTICALS, INC. EXHIBIT 99.1 f8k112514ex99i_delmar.htm EX-99.1 101159
  Complete submission text file 0001013762-14-001400.txt   118352
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54801 | Film No.: 141249870
SIC: 2834 Pharmaceutical Preparations